Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells - ScienceDirect
Frontiers | Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice
Anti Mouse Gr-1 Antibody, clone RB6-8C5 | Bio-Rad
What cells are sorted by CD11b+GR1+ and CD11b+GR1- flow cytometry? | ResearchGate
The markers Gr-1 and CD11b are reactive to MHI-148. Splenocytes from... | Download Scientific Diagram
TNF-induced macrophages express M1 markers. Ly6C+Gr1- and Ly6C-Gr1-... | Download Scientific Diagram
Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging - Cytotherapy
Anti Mouse Gr-1 Antibody, clone RB6-8C5 | Bio-Rad
Gr-1 and Ly6C/Ly6G markers identify similar populations of monocytes... | Download Scientific Diagram
Anti Mouse Gr-1 Antibody, clone RB6-8C5 | Bio-Rad
Elevated markers of DNA damage and senescence are associated with the progression of albuminuria and restrictive lung disease in patients with type 2 diabetes - eBioMedicine
CD38 at the junction between prognostic marker and therapeutic target: Trends in Molecular Medicine
A Guide to Neutrophil Markers | Biocompare: The Buyer's Guide for Life Scientists
The application of cell surface markers to demarcate distinct human pluripotent states - ScienceDirect
Surface marker expression on splenic CD11c+Gr-1+ cells. Low density... | Download Scientific Diagram
DRH1 – a novel blood-based HPV tumour marker - eBioMedicine
Gr1 makes an unexpected cameo appearance in eosinophils - Lacy - 2020 - Journal of Leukocyte Biology - Wiley Online Library
Macrophages and dendritic cells: what is the difference? - ScienceDirect
Optical Deformability as an Inherent Cell Marker for Testing Malignant Transformation and Metastatic Competence: Biophysical Journal
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Nature Communications
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial - The Lancet Oncology
Progenitor stem cell marker expression by pulmonary carcinomas - Modern Pathology
